OnKure Therapeutics, Inc.(OKUR)

Biotechnology · Boulder, CO

$2.42-0.21 (-7.98%)

Delayed quote: Oct 6, 2026, 3:39 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T19:42:46.755Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:42:46.755Z.

Quote observation: 2026-10-06T19:39:43.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 98,001,046
Total debt · period ending 2026-06-30: 926,000
Cash · period ending 2026-06-30: 166,502,000
TTM operating EBITDA · period ending 2026-06-30: -61,343,000

FMP input reference: 352cae2fe5eed9f02885becd1bbca6bb54c51239af0254a5780fc03f1b1dafbc

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

OKUR EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

OKUR Competitors' EV/EBITDA Ratio

OKUR

OnKure Therapeutics, Inc.

Current

Market Cap

$98.00M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KRRO

Korro Bio, Inc.

vs OKUR

Market Cap

$97.49M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PYPD

PolyPid Ltd.

vs OKUR

Market Cap

$97.52M

EV/EBITDA Ratio

N/A

TTM Avg

57.81x

3Y Avg

57.81x

5Y Avg

8.19x

PARK

Park Dental Partners, Inc. Common Stock

vs OKUR

Market Cap

$96.58M

EV/EBITDA Ratio

N/A

TTM Avg

51.11x

3Y Avg

51.11x

5Y Avg

51.11x

MIST

Milestone Pharmaceuticals Inc.

vs OKUR

Market Cap

$94.81M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNXU

Conexeu Sciences Inc.

vs OKUR

Market Cap

$96.46M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JYNT

The Joint Corp.

vs OKUR

Market Cap

$101.22M

EV/EBITDA Ratio

25.66x

TTM Avg

52.21x

3Y Avg

97.08x

5Y Avg

75.85x

ANIX

Anixa Biosciences, Inc.

vs OKUR

Market Cap

$102.92M

EV/EBITDA Ratio

N/A

TTM Avg

65.13x

3Y Avg

65.13x

5Y Avg

65.13x

PLYX

Polaryx Therapeutics, Inc. Common Stock

vs OKUR

Market Cap

$104.18M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BDTX

Black Diamond Therapeutics, Inc.

vs OKUR

Market Cap

$104.00M

EV/EBITDA Ratio

N/A

TTM Avg

20.17x

3Y Avg

20.17x

5Y Avg

20.17x

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
OnKure Therapeutics, Inc. (OKUR)	$98.00M	N/A	N/A	N/A	N/A
Korro Bio, Inc. (KRRO)vs ›	$97.49M	N/A	N/A	N/A	N/A
PolyPid Ltd. (PYPD)vs ›	$97.52M	N/A	57.81x	57.81x	8.19x
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$96.58M	N/A	51.11x	51.11x	51.11x
Milestone Pharmaceuticals Inc. (MIST)vs ›	$94.81M	N/A	N/A	N/A	N/A
Conexeu Sciences Inc. (CNXU)vs ›	$96.46M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$101.22M	25.66x	52.21x	97.08x	75.85x
Anixa Biosciences, Inc. (ANIX)vs ›	$102.92M	N/A	65.13x	65.13x	65.13x
Polaryx Therapeutics, Inc. Common Stock (PLYX)vs ›	$104.18M	N/A	N/A	N/A	N/A
Black Diamond Therapeutics, Inc. (BDTX)vs ›	$104.00M	N/A	20.17x	20.17x	20.17x

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics